Lista de obras - Martin Taphoorn - Dominio Público Uruguay

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

artículo científico publicado en 2006

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

artículo científico publicado en 2012

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

artículo científico publicado en 2006

Advance Care Planning in Glioblastoma Patients

artículo científico publicado en 2016

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

artículo científico publicado en 2010

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards ⬇️

artículo científico publicado en 2016

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study

artículo científico publicado en 2015

Cerebral ganglioneuroblastoma of adult onset: two patients and a review of the literature

artículo científico publicado en 2012

Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).

artículo científico publicado en 2002

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

artículo científico publicado en 2014

Cognitive deficits in adult patients with brain tumours

artículo científico publicado en 2004

Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.

artículo científico publicado en 2009

Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases

artículo científico publicado en 2006

Does early resection of presumed low-grade glioma improve survival? A clinical perspective.

artículo científico publicado en 2017

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data

artículo científico publicado en 2011

Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials.

artículo científico publicado en 2015

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2010

Impact of brain tumour treatment on quality of life

artículo científico publicado en 2002

Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.

artículo científico publicado en 2016

Interventions for cognitive deficits in adults with brain tumours

artículo científico publicado en 2008

Interventions for cognitive deficits in patients with a brain tumor: an update ⬇️

artículo científico publicado el 1 de noviembre de 2010

Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation

artículo científico publicado en 2014

Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation

artículo científico publicado en 2014

Joint modeling of longitudinal health-related quality of life data and survival

artículo científico publicado en 2014

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

artículo científico publicado en 2009

Management of temozolomide toxicity by nurse practitioners in neuro-oncology

artículo científico publicado en 2009

NCO-04A PILOT RCT ON THE EFFICACY OF E-HEALTH SUPPORTED PHYSICAL EXERCISE TO IMPROVE COGNITIVE FUNCTIONING IN GLIOMA PATIENTS.

artículo científico publicado en 2015

Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study

artículo científico publicado en 2015

Neurocognitive sequelae in the treatment of low-grade gliomas

artículo científico publicado en 2003

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

artículo científico publicado en 2010

Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry

artículo científico publicado en 2014

Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival

artículo científico publicado en 2011

Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas

artículo científico publicado en 2010

Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma

artículo científico publicado en 2015

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis

artículo científico publicado en 2010

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

artículo científico publicado en 2007

Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients

artículo científico publicado en 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

artículo científico publicado en 2005

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

artículo científico publicado en 2009

Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review

artículo científico publicado en 2015

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

artículo científico publicado en 2015

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

artículo científico publicado en 2014

Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide

artículo científico publicado en 2012

Symptomatic management and imaging of brain metastases

artículo científico publicado en 2005

Symptoms and problems in the end-of-life phase of high-grade glioma patients

artículo científico publicado en 2010

The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative ⬇️

artículo científico publicado en 2015

The association between cognitive functioning and health-related quality of life in low-grade glioma patients

artículo científico publicado en 2014

The course of neurocognitive functioning in high-grade glioma patients.

artículo científico publicado en 2006

The end-of-life phase of high-grade glioma patients: dying with dignity?

artículo científico publicado en 2013

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study

artículo científico publicado en 2014

Lista de obras de Martin Taphoorn

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

Advance Care Planning in Glioblastoma Patients

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards ⬇️

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study

Cerebral ganglioneuroblastoma of adult onset: two patients and a review of the literature

Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Cognitive deficits in adult patients with brain tumours

Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.

Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases

Does early resection of presumed low-grade glioma improve survival? A clinical perspective.

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data

Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials.

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Impact of brain tumour treatment on quality of life

Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.

Interventions for cognitive deficits in adults with brain tumours

Interventions for cognitive deficits in patients with a brain tumor: an update ⬇️

Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation

Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation

Joint modeling of longitudinal health-related quality of life data and survival

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

Management of temozolomide toxicity by nurse practitioners in neuro-oncology

NCO-04A PILOT RCT ON THE EFFICACY OF E-HEALTH SUPPORTED PHYSICAL EXERCISE TO IMPROVE COGNITIVE FUNCTIONING IN GLIOMA PATIENTS.

Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study

Neurocognitive sequelae in the treatment of low-grade gliomas

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry

Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival

Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas

Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide

Symptomatic management and imaging of brain metastases

Symptoms and problems in the end-of-life phase of high-grade glioma patients

The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative ⬇️

The association between cognitive functioning and health-related quality of life in low-grade glioma patients

The course of neurocognitive functioning in high-grade glioma patients.

The end-of-life phase of high-grade glioma patients: dying with dignity?

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study